The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1)

Oncotarget
T GoiAkio Yamaguchi

Abstract

The angiogenic proteins vascular endothelial growth factor (VEGF) and prokineticin1 (PROK1) proteins are considered important in colorectal cancer, the relationship between their simultaneous expression and prognosis was investigated in the present study. VEGF and PROK1 expression in 620 primary human colorectal cancer lesions was confirmed via immunohistochemical staining with anti-VEGF and anti-PROK1 antibodies, and the correlation between the expression of these 2 proteins and recurrence/prognosis were investigated. VEGF protein was expressed in 329 (53.1%) and PROK1 protein was expressed in 223 (36.0%). PROK1 and VEGF were simultaneously expressed in 116 (18.7%) of the 620 cases. The correlation coefficient between VEGF expression and PROK1 expression was r = 0.11, and therefore correlation was not observed. Clinical pathology revealed that substantially lymphnode matastasis, hematogenous metastasis, or TMN advanced-stage IV was significantly more prevalent in cases that expressed both VEGF and PROK1 than in the cases negative for both proteins or those positive for only 1 of the proteins. Also the cases positive for both proteins exhibited the worst recurrence and prognosis. In the Cox proportional hazards model, VEGF and ...Continue Reading

References

Sep 30, 1992·Biochemical and Biophysical Research Communications·B I TermanP Böhlen
Jun 15, 1989·Biochemical and Biophysical Research Communications·N Ferrara, W J Henzel
Aug 5, 2006·Molecular Pharmacology·Qingdong Ke, Max Costa
Dec 22, 2006·Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland·K A RmaliW G Jiang
Feb 10, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Elly S W NganPaul K H Tam
Aug 9, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Angélica MoralesVicente Díaz-Sánchez
Sep 6, 2007·Journal of Surgical Oncology·Hideki NaganoAkio Yamaguchi
May 24, 2008·Nature Reviews. Cancer·Christie J AvraamidesJudith A Varner
May 31, 2008·Arteriosclerosis, Thrombosis, and Vascular Biology·Xuri LiLieve Moons
Dec 17, 2008·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Xiaohua JiangJörg Kleeff
Dec 17, 2009·Cytokine & Growth Factor Reviews·Napoleone Ferrara
Jul 17, 2010·Cancer Letters·Justin Monnier, Michel Samson
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Aug 3, 2013·The Journal of Clinical Investigation·Jonathan WeltiPeter Carmeliet
Oct 3, 2013·Cancer Chemotherapy and Pharmacology·Michalis AlevizakosKonstantinos N Syrigos
Nov 23, 2013·Nature Reviews. Cancer·Hira Lal Goel, Arthur M Mercurio
Jul 6, 2014·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Do Joong ParkSam S Yoon
Mar 19, 2015·International Journal of Clinical Oncology·Toshiaki WatanabeUNKNOWN Japanese Society for Cancer of the Colon and Rectum

❮ Previous
Next ❯

Software Mentioned

Stat Mate IV
SPSS

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.